GPC3 and cancer: Furthermore, coupling human monoclonal antibody GC33 (ligand of GPC3) onto Macropa (named 225Ac-Macropa-GC33) can achieve targeted radiotherapy of GPC3-overexpressing HepG2 cancer cells.